Actionnariat et activité des initiés pour AngioDynamics, Inc. (ANGO): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $15.46 |
| Capitalisation | $639M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-07-30 | Nighan Warren JR | S-Sale | 23,370 | $344K |
| 2026-07-22 | Piccinini Laura | M-Exempt | 8,047 | |
| 2026-07-22 | Piccinini Laura | F-InKind | 4,506 | $62K |
| 2026-07-22 | Piccinini Laura | M-Exempt | 28,336 | |
| 2026-07-22 | Nighan Warren JR | M-Exempt | 5,694 | |
| 2026-07-22 | Nighan Warren JR | F-InKind | 1,671 | $23K |
| 2026-07-22 | Nighan Warren JR | M-Exempt | 20,052 | |
| 2026-07-22 | Trowbridge Stephen A | M-Exempt | 16,296 | |
| 2026-07-22 | Trowbridge Stephen A | F-InKind | 8,319 | $115K |
| 2026-07-22 | Trowbridge Stephen A | M-Exempt | 57,381 |
Bilan (10 ans)
| Année | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $47.5M | $74.1M | $227.6M | $54.4M | $48.2M | $28.8M | $44.6M | $76.1M | $55.9M | $53.9M |
| Placements à Court Terme | $1.2M | $1.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Créances | $46.4M | $39.4M | $43.6M | $34.2M | $37.3M | $56.5M | $52.8M | $50.0M | $43.1M | $48.3M |
| Stocks | $54.5M | $39.3M | $40.1M | $59.9M | $48.6M | $51.4M | $55.3M | $60.6M | $62.0M | $52.4M |
| Actifs Courants | $153.9M | $168.0M | $315.3M | $152.9M | $140.9M | $143.3M | $163.5M | $193.3M | $168.3M | $163.4M |
| Immobilisations Corporelles | $45.2M | $25.7M | $24.3M | $28.3M | $37.1M | $45.0M | $44.4M | $35.7M | $32.3M | $27.1M |
| Goodwill | $361.3M | $361.3M | $347.7M | $201.5M | $201.3M | $201.1M | $159.2M | 0 | 0 | 0 |
| Actifs Incorporels | $145.7M | $130.3M | $145.4M | $197.1M | $169.0M | $152.4M | $111.1M | $77.4M | $69.1M | $67.2M |
| Actifs Totaux | $708.0M | $705.5M | $836.4M | $595.5M | $561.4M | $552.8M | $532.6M | $317.7M | $280.1M | $267.2M |
| Dettes Fournisseurs | $18.1M | $15.8M | $22.8M | $19.1M | $19.6M | $28.0M | $40.4M | $37.8M | $33.3M | $31.5M |
| Dette à Court Terme | $14.6M | $7.1M | $12.1M | $836000 | 0 | $8.8M | $14.8M | $4.7M | $400000 | 0 |
| Passifs Courants | $69.5M | $57.3M | $73.3M | $51.5M | $57.6M | $74.3M | $83.8M | $91.2M | $76.2M | $74.7M |
| Dette à Long Terme | $91.3M | $86.6M | $124.4M | $40.0M | $20.0M | $25.0M | $49.8M | 0 | $5.8M | 0 |
| Passifs Totaux | $190.9M | $162.9M | $221.6M | $139.6M | $122.0M | $128.3M | $154.3M | $112.1M | $97.2M | $96.3M |
| Réserves | -$11.0M | $5.1M | $66.5M | -$100.3M | -$131.9M | -$158.4M | -$210.9M | -$395.2M | -$429.2M | -$465.9M |
| Capitaux Propres | $517.0M | $542.6M | $614.8M | $455.9M | $439.5M | $424.5M | $378.3M | $205.6M | $183.0M | $170.8M |
| Dette Totale | $105.9M | $93.7M | $136.5M | $40.8M | $20.0M | $33.8M | $64.6M | $4.7M | $10.1M | 0 |
| Dette Nette | $57.2M | $18.3M | -$91.1M | -$13.6M | -$28.2M | $5.0M | $20.0M | -$71.3M | -$45.7M | -$53.9M |
| Fonds de Roulement | $84.4M | $110.7M | $242.0M | $101.4M | $83.3M | $69.0M | $79.7M | $102.1M | $92.1M | $88.7M |
Santé financière
| Dette / Capitaux propres | 0.00 |
| Ratio de liquidité | 2.19 |
| Piotroski F-Score | 5 |
| Altman Z-Score | 1.48 |
Rentabilité
| Rentabilité des capitaux propres | -21.01% |
| Rentabilité du capital investi | -20.75% |
| Rentabilité des actifs | -13.75% |
| Marge brute | 54.62% |
| Marge opérationnelle | -12.47% |
| Marge nette | -11.48% |
Entreprises liées: CGEM · FULC · LAB · NMRA · OCGN · OMER · RAPT
Explorer le secteur: Healthcare · Medical - Instruments & Supplies
Plus de sections de ANGO: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions